Streetbeat News

Earnings

AFL

Aflac (NYSE:AFL) has been analyzed by 6 analysts, showing a mix of bullish to bearish sentiments with an average 12-month price target of $84.17, indicating a 4.99% increase from the previous target. The company faces revenue challenges with a -2.5% decline but shows strong profitability and financial performance with impressive net margin, ROE, and ROA. Aflac's market position is robust, with a significant market capitalization and a sound financial structure.

Portfolio Pulse from Benzinga Insights

April 05, 2024 | 3:01 pm

CSCO

This article provides an in-depth comparison of Cisco Systems (NASDAQ:CSCO) with its competitors in the Communications Equipment industry, focusing on financial metrics like P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth. Cisco Systems is highlighted for its favorable growth potential, strong profitability, and robust cash flow generation, despite a potential overvaluation based on revenue and lower profitability compared to industry peers. The analysis suggests Cisco may be undervalued based on its P/E and P/B ratios but overvalued based on its P/S ratio.

Portfolio Pulse from Benzinga Insights

April 05, 2024 | 3:00 pm

LLY

Eli Lilly and Co (NYSE:LLY) is analyzed in comparison to its competitors in the Pharmaceuticals industry, focusing on financial metrics, market position, and growth prospects. Eli Lilly shows a premium valuation with a high P/E, P/B, and P/S ratios compared to industry averages. Despite this, the company demonstrates strong profitability with a higher ROE and significant revenue growth. However, concerns are raised due to its lower EBITDA, gross profit, and a higher debt-to-equity ratio, indicating potential financial vulnerability and operational inefficiencies.

Portfolio Pulse from Benzinga Insights

April 05, 2024 | 3:00 pm

XOM

Exxon Mobil (NYSE:XOM) has seen significant options trading activity, with a bullish sentiment prevailing among investors. Analysis of 13 trades reveals a majority bullish outlook, with 53% of trades being bullish and 46% bearish. The trades include 3 puts and 10 calls, with a notable interest in strike prices ranging from $110.0 to $130.0. The largest trades indicate a mix of bullish and bearish sentiments on specific call options. Exxon Mobil, a major oil and gas company, has a current stock price of $120.32, with analysts giving it an average target price of $127.6. The company's next earnings are expected in 21 days, and it's considered potentially overbought based on RSI indicators.

Portfolio Pulse from Benzinga Insights

April 05, 2024 | 2:46 pm

SGH

SMART Global Holdings, Inc. (NASDAQ:SGH) is anticipated to release its Q2 earnings after the market closes on April 9, 2024, with analysts expecting a decrease in earnings per share from 76 cents to 25 cents year-over-year, and a projected quarterly revenue of $283.79 million. The company previously announced a $75 million share repurchase authorization. Shares fell 2% to $25.49 recently. Analysts from Needham, Rosenblatt, Deutsche Bank, and Barclays have provided updated ratings and price targets for SGH.

Portfolio Pulse from Avi Kapoor

April 05, 2024 | 2:38 pm

TSLA

The article discusses concerns about Tesla (NASDAQ:TSLA), highlighting a recent bad delivery number and the company's decision to not slow manufacturing production despite a slowdown in demand. The author believes this strategy risks creating too much inventory, potentially leading to future write downs and earnings hits, especially if the economy slows next year. The article also mentions Tesla's Full Self-Driving (FSD) feature not nearing regulatory approval, which adds to the stock risk. The author, previously a Tesla bull, remains cautious and sees no immediate change in their stance.

Portfolio Pulse from Elazar Advisors

April 05, 2024 | 2:35 pm

LLY

Eli Lilly and Co (NYSE:LLY) has seen significant options trading activity, with a bearish sentiment prevailing among investors. Analysis of 22 trades revealed 40% bullish and 59% bearish positions, with a focus on strike prices between $490.0 and $830.0. The volume and open interest in options suggest that big players are targeting this price range. Notably, the largest trades include both bullish and bearish calls with expiration dates ranging from April 2024 to September 2024. Eli Lilly, a pharmaceutical company specializing in various therapeutic areas, currently has its stock price at $763.86, showing a slight decrease. The company's next earnings report is expected in 25 days, and the RSI indicators suggest the stock may be nearing overbought territory.

Portfolio Pulse from Benzinga Insights

April 05, 2024 | 2:31 pm

ATUS

HLF

ZGN

Ermenegildo Zegna N.V. (ZGN) reported a significant increase in FY23 profits, yet shares fell 14%. Other stocks like Altice USA (ATUS), DoubleDown Interactive (DDI), and Herbalife (HLF) also saw declines. Altice was downgraded by Wells Fargo, and Herbalife is anticipated to release Q1 2024 results soon.

Portfolio Pulse from Avi Kapoor

April 05, 2024 | 2:27 pm

AZN

AstraZeneca Plc (NASDAQ:AZN) announced promising results from the ADRIATIC Phase 3 trial of Imfinzi, either alone or with Imjudo, in treating small cell lung cancer (LS-SCLC) post-chemoradiotherapy. The trial, involving 730 patients, showed significant improvements in overall and progression-free survival compared to placebo. Imfinzi's safety profile remained consistent, with no new safety concerns. The study's second arm, evaluating Imjudo's addition, continues to its next analysis phase. Imfinzi is already approved in multiple regions for different stages of lung cancer.

Portfolio Pulse from Vandana Singh

April 05, 2024 | 2:19 pm

BYND

HYG

LQD

The U.S. corporate bond market showed mixed performance in Q1 2024, with high-grade bonds slightly down and high-yield bonds up, as indicated by LQD and HYG ETFs respectively. Top performers included bonds from Macy's, Ally Financial, and Beyond Meat, with Beyond Meat's bonds notably outperforming its shares due to improved revenue and cost-cutting measures.

Portfolio Pulse from Piero Cingari

April 05, 2024 | 2:09 pm